Companies/iAnthus Capital Holdings, Inc.

Company profile

iAnthus Capital Holdings, Inc.

OTC: ITHUF · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Toronto, NYCIK 0001643154Reports USD

#313 of 1,394 Healthcare companies by revenue30th-percentile growth

EA Score

46D

FH 47DQ 41GM 47SS 60

v0.1 · 65/100 weight · provisional

↑ workforce scale, growth stability · ↓ Piotroski F, balance-sheet leverage

Methodology →

Revenue TTM

$139.9M

Rev growth YoY (TTM)

-14.3%

Net income (FY)

-$40.2M

Employees

716

Market cap

$34.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$144.0M$144.0M2025

Net income-$40.2M-$40.2M2025

Operating income-$15.4M-$15.4M2025

Total assets$256.0M$256.0M2025

Liabilities$359.0M$359.0M2025

Equity-$103.0M-$103.0M2025

Revenue trend

FY2021 – FY2025 · USD

$151.7M

FY21

$203.0M

FY21

$163.2M

FY22

$159.2M

FY23

$167.6M

FY24

$144.0M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

iAnthus Branded Products44%

Third Party Branded Products38%

Wholesale Bulk Other Products18%

By geography

Eastern Region93%

Western Region7%

The read

iAnthus Capital Holdings, Inc. booked $144.0M in FY2025 revenue, contracting 14% year over year — slower than 70% of Healthcare companies we track, at a -27.9% net margin.

Peers · Healthcare

CareView Communications, Inc.52D Aligos Therapeutics, Inc.47D Dyadic International, Inc.39D RenovoRx, Inc.32D

Key facts

CEORichard Proud

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, NY

ExchangeOTC: ITHUF

Employees716

IPO date2018-03-02

Latest filings

8-K2026-07-01 DEF 14A2026-05-19 8-K2026-05-12 10-Q2026-05-12 8-K2026-05-05 10-K2026-03-27 8-K2026-03-27 8-K2026-02-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.